Synonym
RGDV TFA; Arg-Gly-Asp-Val-OH; RGDV (trifluoroacetate salt)
IUPAC/Chemical Name
(6S,12S,15S)-1,6-diamino-12-(carboxymethyl)-1-imino-15-isopropyl-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid--2,2,2-trifluoroacetic acid (1/1)
InChi Key
ZCTAWGFLPLOTHC-JMHMRROLSA-N
InChi Code
InChI=1S/C17H31N7O7.C2HF3O2/c1-8(2)13(16(30)31)24-15(29)10(6-12(26)27)23-11(25)7-22-14(28)9(18)4-3-5-21-17(19)20;3-2(4,5)1(6)7/h8-10,13H,3-7,18H2,1-2H3,(H,22,28)(H,23,25)(H,24,29)(H,26,27)(H,30,31)(H4,19,20,21);(H,6,7)/t9-,10-,13-;/m0./s1
SMILES Code
CC(C)[C@@H](C(O)=O)NC([C@H](CC(O)=O)NC(CNC([C@@H](N)CCCNC(N)=N)=O)=O)=O.OC(C(F)(F)F)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
559.50
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1. Park, H.S., Kim, C., and Kang, Y.K. Preferred conformations of RGDX tetrapeptides to inhibit the binding of fibrinogen to platelets. Biopolymers 63(5), 298-313 (2002).
2. Tranqui, L., Andrieux, A., Hudry-Clergeon, G., et al. Differential structural requirements for fibrinogen binding to platelets and to endothelial cells. J. Cell Biol. 108(6), 2519-2527 (1989).
3. Zhang, X., Zhang, J., Liu, W., et al. Exploring the action of RGDV-gemcitabine on tumor metastasis, tumor growth and possible action pathway. Sci. Rep. 10(1), 15729 (2020).
